CN102223895A - 生产pH稳定的包膜病毒的方法 - Google Patents
生产pH稳定的包膜病毒的方法 Download PDFInfo
- Publication number
- CN102223895A CN102223895A CN2009801471023A CN200980147102A CN102223895A CN 102223895 A CN102223895 A CN 102223895A CN 2009801471023 A CN2009801471023 A CN 2009801471023A CN 200980147102 A CN200980147102 A CN 200980147102A CN 102223895 A CN102223895 A CN 102223895A
- Authority
- CN
- China
- Prior art keywords
- virus
- cell
- influenza
- influenza virus
- viral
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16051—Methods of production or purification of viral material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Microbiology (AREA)
- Organic Chemistry (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
Claims (14)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11790008P | 2008-11-25 | 2008-11-25 | |
US61/117,900 | 2008-11-25 | ||
EP09153664.9 | 2009-02-25 | ||
EP09153664 | 2009-02-25 | ||
PCT/EP2009/065812 WO2010060921A1 (en) | 2008-11-25 | 2009-11-25 | METHOD FOR PRODUCTION OF pH STABLE ENVELOPED VIRUSES |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102223895A true CN102223895A (zh) | 2011-10-19 |
CN102223895B CN102223895B (zh) | 2014-11-05 |
Family
ID=40626824
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN200980147102.3A Active CN102223895B (zh) | 2008-11-25 | 2009-11-25 | 生产pH稳定的包膜病毒的方法 |
Country Status (8)
Country | Link |
---|---|
US (3) | US8815252B2 (zh) |
EP (1) | EP2364167B1 (zh) |
JP (1) | JP5762969B2 (zh) |
KR (1) | KR101741848B1 (zh) |
CN (1) | CN102223895B (zh) |
CA (1) | CA2744354C (zh) |
EA (1) | EA024262B1 (zh) |
WO (1) | WO2010060921A1 (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104302317A (zh) * | 2012-05-16 | 2015-01-21 | Kj生物科学有限公司 | 新型和改进的流感疫苗 |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010060921A1 (en) * | 2008-11-25 | 2010-06-03 | Avir Green Hills Biotechnology Research Development Trade Ag | METHOD FOR PRODUCTION OF pH STABLE ENVELOPED VIRUSES |
WO2011102900A1 (en) | 2010-02-18 | 2011-08-25 | Technovax, Inc. | Universal virus-like particle (vlp) influenza vaccines |
US20130183740A1 (en) * | 2010-06-02 | 2013-07-18 | Avir Green Hills Biotechnology Research Development Trade Ag | Novel method for generation of rna virus |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL140264A0 (en) | 1998-06-12 | 2002-02-10 | Sinai School Medicine | Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals |
PT1098961E (pt) | 1998-06-12 | 2008-04-23 | Mount Sinai School Of Med Of T | Vírus atenuados produzidos por engenharia genética indutores de interferão |
WO2004022716A2 (en) * | 2002-09-09 | 2004-03-18 | University Of Tennessee Research Foundation | Recombinatant mutants of rhabdovirus and methods of use thereof |
EP1597400B8 (en) | 2003-02-25 | 2013-10-09 | MedImmune, LLC | Methods of producing influenza vaccine compositions |
EP2581093B1 (en) * | 2003-06-16 | 2015-03-18 | MedImmune, LLC | Influenza hemagglutinin and neuraminidase variants |
DE102004049290A1 (de) * | 2004-10-09 | 2006-04-20 | Bayer Healthcare Ag | Verfahren zur Herstellung von Virusmaterial |
EP1911836A1 (en) * | 2006-10-12 | 2008-04-16 | AVIR Green Hills Biotechnology Trading GmbH | Medium supplement for virus production |
WO2010060921A1 (en) * | 2008-11-25 | 2010-06-03 | Avir Green Hills Biotechnology Research Development Trade Ag | METHOD FOR PRODUCTION OF pH STABLE ENVELOPED VIRUSES |
-
2009
- 2009-11-25 WO PCT/EP2009/065812 patent/WO2010060921A1/en active Application Filing
- 2009-11-25 JP JP2011537962A patent/JP5762969B2/ja active Active
- 2009-11-25 US US13/129,806 patent/US8815252B2/en active Active
- 2009-11-25 CN CN200980147102.3A patent/CN102223895B/zh active Active
- 2009-11-25 US US12/626,475 patent/US8883479B2/en active Active
- 2009-11-25 EA EA201100845A patent/EA024262B1/ru not_active IP Right Cessation
- 2009-11-25 EP EP09760521.6A patent/EP2364167B1/en active Active
- 2009-11-25 CA CA2744354A patent/CA2744354C/en active Active
- 2009-11-25 KR KR1020117011829A patent/KR101741848B1/ko active IP Right Grant
-
2014
- 2014-08-25 US US14/468,131 patent/US20140377308A1/en not_active Abandoned
Non-Patent Citations (1)
Title |
---|
MAASSAB H F: "biologic and immunologic characteristic of cold-adapted influenza virus", 《JOURNAL OF IMMUNOLOGY》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104302317A (zh) * | 2012-05-16 | 2015-01-21 | Kj生物科学有限公司 | 新型和改进的流感疫苗 |
CN104302317B (zh) * | 2012-05-16 | 2016-07-06 | Kj生物科学有限公司 | 新型和改进的流感疫苗 |
Also Published As
Publication number | Publication date |
---|---|
US20100172934A1 (en) | 2010-07-08 |
US8815252B2 (en) | 2014-08-26 |
EA201100845A1 (ru) | 2011-10-31 |
EP2364167B1 (en) | 2016-08-17 |
EP2364167A1 (en) | 2011-09-14 |
KR20110092280A (ko) | 2011-08-17 |
CN102223895B (zh) | 2014-11-05 |
CA2744354A1 (en) | 2010-06-03 |
US20140377308A1 (en) | 2014-12-25 |
WO2010060921A1 (en) | 2010-06-03 |
KR101741848B1 (ko) | 2017-05-30 |
JP5762969B2 (ja) | 2015-08-12 |
US8883479B2 (en) | 2014-11-11 |
JP2012509684A (ja) | 2012-04-26 |
US20110223199A1 (en) | 2011-09-15 |
CA2744354C (en) | 2018-10-02 |
EA024262B1 (ru) | 2016-09-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Chen et al. | Advances in development and application of influenza vaccines | |
Baigent et al. | Influenza type A in humans, mammals and birds: Determinants of virus virulence, host‐range and interspecies transmission | |
US8691238B2 (en) | High growth reassortant influenza A virus | |
Voeten et al. | Characterization of high-growth reassortant influenza A viruses generated in MDCK cells cultured in serum-free medium | |
CN102781469B (zh) | 用于生产流感疫苗的方法 | |
Zhang et al. | Hemagglutinin glycosylation modulates the pathogenicity and antigenicity of the H5N1 avian influenza virus | |
US8597661B2 (en) | Neuraminidase-deficient live influenza vaccines | |
Steel et al. | A combination in-ovo vaccine for avian influenza virus and Newcastle disease virus | |
US8715691B2 (en) | Swine influenza hemagglutinin variants | |
US10494613B2 (en) | Generation of infectious influenza viruses from virus-like particles | |
Silva et al. | Recent advances and current challenges in process intensification of cell culture‐based influenza virus vaccine manufacturing | |
CN102223895B (zh) | 生产pH稳定的包膜病毒的方法 | |
CN104780936A (zh) | 猪流感血球凝集素与神经氨酸酶变体 | |
CN102239250A (zh) | 用于生成rna病毒的新方法 | |
CN103237890A (zh) | 用于产生rna 病毒的方法和辅助病毒 | |
WO2010046335A1 (en) | Production of influenza virus by reverse genetics in per.c6 cells under serum free conditions | |
Lee et al. | Cell-cultured, live attenuated, X-31ca-based H5N1 pre-pandemic influenza vaccine | |
Silva et al. | 9 Manufacturing of seasonal and pandemic | |
Youil et al. | Phenotypic and genetic analyses of the heterogeneous population present in the cold-adapted master donor strain: A/Leningrad/134/17/57 (H2N2) | |
Marzio et al. | Production of viruses, viral isolates and vaccines | |
Larionova et al. | Journal of Vaccines & Vaccination | |
Yassine | Studies on Interspecies and Intraspecies Transmission of Influenza A Viruses | |
Sweet | Virulence studies associated with influenza A/Ann Arbor/6/60 | |
Sorrell | Molecular markers of interspecies transmission of H2N2 and H9N2 avian influenza A viruses | |
Sorrell | Adaptation of A/Mallard/Potsdam/178-4/83 (H2N2) in Japanese quail leads to replicaton and transmission in chickens |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: BAKST HELTH CO., LTD. Free format text: FORMER OWNER: AVIR GREEN HILLS BIOTECHNOLOGY Effective date: 20130620 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20130620 Address after: Swiss Aupu Applicant after: BAXTER HEALTHCARE S.A. Address before: Austria Vienna Applicant before: AVIR GREEN HILLS BIOTECHNOLOGY RESEARCH DEVELOPMENT TRADE AG |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20161010 Address after: American Florida Patentee after: nanomedicine Address before: Swiss Aupu Patentee before: Baxalta LLC Effective date of registration: 20161010 Address after: Swiss Aupu Patentee after: Baxalta LLC Address before: Swiss Aupu Patentee before: BAXTER HEALTHCARE S.A. |